<div class="container">
<div class="row">
<div class="col-md-12"><meta charset="utf-8">
<h1>Projects</h1>
&nbsp;

<blockquote class="blockquote">
<p class="mb-0">&quot;Predicting adverse response to thiopurines in IBD patients using exome sequencing data.&quot;</p>

<footer class="blockquote-footer">Michiel Voskuil</footer>
</blockquote>

<blockquote class="blockquote">
<p class="mb-0">&quot;Single cell RNA sequencing of immune cells from CD patients&quot;</p>

<footer class="blockquote-footer">W. Uniken Venema, M. Voskuil</footer>
</blockquote>

<blockquote class="blockquote">
<p class="mb-0">&quot;Identifying genetic factors that affect IBD disease course&quot;</p>

<footer class="blockquote-footer">M. Voskuil, Y. Li</footer>
</blockquote>

<blockquote class="blockquote">
<p class="mb-0">&quot;Optimizing the diagnostic process for inflammatory bowel disease and irritable bowel syndrome using non-invasive faecal biomarkers&quot;</p>

<footer class="blockquote-footer">R. Gacesa</footer>
</blockquote>

<blockquote class="blockquote">
<p class="mb-0">&quot;Increased abundances of pro-inflammatory pathways and virulence factors during Crohn&#39;s disease exacerbations&quot;</p>

<footer class="blockquote-footer">M. Klaassen, F. Imhann, A. Vich Vila</footer>
</blockquote>

<blockquote class="blockquote">
<p class="mb-0">&quot;Patient attitudes towards faecal sampling&quot;</p>

<footer class="blockquote-footer">M. Klaassen</footer>
</blockquote>

<blockquote class="blockquote">
<p class="mb-0">&quot;Predicting response to treatment of inflammatory bowel diseases with Vedolziumab based on metagenomics and transcriptomic analyses&quot;</p>

<footer class="blockquote-footer">V. Collij, M. Klaassen</footer>
</blockquote>

<blockquote class="blockquote">
<p class="mb-0">&quot;Predicting response to treatment of Crohn&#39;s disease with Ustekinumab based on metagenomics analyses&quot;</p>

<footer class="blockquote-footer">V. Collij, M. Klaassen</footer>
</blockquote>
</div>
</div>
</div>
